HT
DOVA

HAP Trading’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

HAP Trading’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-65,264
Closed -$920K – 1569
2019
Q2 		$920K Buy
+65,264
New +$621K 0.07% 229

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's DOVA Position: Q3 2019 in Review

HAP Trading sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 65,264 shares — an estimated $920K sold.

HAP Trading first reported a position in DOVA in Q2 2019 and held it in 1 quarter. The position peaked at $920K in Q2 2019. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

  • HAP Trading reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • HAP Trading sold 65,264 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $920K.
  • HAP Trading first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • HAP Trading's Dova Pharmaceuticals, Inc. Common Stock position peaked at $920K in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.